All News

PARIS -- Children exposed to extensive phototherapy to treat neonatal jaundice had twice as many moles at age nine as controls, found a small case-control study.

PARIS -- Children exposed to extensive phototherapy to treat neonatal jaundice had twice as many moles at age nine as controls, found a small case-control study.

ROCKVILLE, Md. -- Two patients treated with the immune modulator Rituxan (rituximab) for systemic lupus erythmatosus have died of progressive multifocal leukoencephalopathy (PML), the FDA warned physicians.

BOSTON -- Higher circulating levels of 25-hydroxyvitamin D have been associated with a lower risk of multiple sclerosis, researchers here reported.

HOUSTON -- Cromolyn, an old-line asthma and allergy drug, has shown a marked effect on the progress of pancreatic cancer - at least in mice.

SAN ANTONIO -- Abraxane, the nanoparticle albumin-bound form of paclitaxel, appears effective against metastatic breast cancer in combination with Xeloda (capecitabine), according to a small study.

SAN ANTONIO -- Abraxane, the nanoparticle albumin-bound form of paclitaxel, appears effective against metastatic breast cancer in combination with Xeloda (capecitabine), according to a small study.

SAN ANTONIO -- Tamoxifen has a "true preventive effect" on breast cancer in women with a strong family history of the disease -- but it may take several years before the benefit is seen.

SAN ANTONIO -- Tamoxifen has a "true preventive effect" on breast cancer in women with a strong family history of the disease -- but it may take several years before the benefit is seen.

SAN ANTONIO -- Breast cancer clinicians seem to be on the right track with their use of radiotherapy, chemotherapy regimens, and tamoxifen, showing a major mortality decline, according to a meta-analysis of clinical trial evidence.

SEATTLE -- Black cohosh alone or with other botanical therapies was no better than placebo at relieving hot flashes or other vasomotor symptoms associated with menopause, found the Herbal Alternatives for Menopause (HALT) trial.

TORONTO -- A drink or two may protect against death from a hard blow to the head, researchers here reported.

TORONTO -- A drink or two may protect against death from a hard blow to the head, researchers here reported.

MELBOURNE, Australia -- Rapidly growing primary cutaneous melanomas have characteristic features that signal the need for immediate and aggressive medical intervention, said researchers here.

MELBOURNE, Australia -- Rapidly growing primary cutaneous melanomas have characteristic features that signal the need for immediate and aggressive medical intervention, said researchers here.

SAN ANTONIO -- If a big study of the post-tamoxifen use of Aromasin (exemestane) for early breast caner had gone to its conclusion, the aromatase inhibitor would have fared as well as Femara (letrozole), a competitor, an investigator reported here.

SAN ANTONIO -- If a big study of the post-tamoxifen use of Aromasin (exemestane) for early breast caner had gone to its conclusion, the aromatase inhibitor would have fared as well as Femara (letrozole), a competitor, an investigator reported here.

SAN ANTONIO -- The combination of investigational Tykerb (lapatinib) and Taxol (paclitaxel) as neoadjuant chemotherapy appears effective against inflammatory breast cancer, according to a small study.